Michelle Cunningham | Business Development Manager
Clinical Network Services USA Inc

Michelle Cunningham, Business Development Manager, Clinical Network Services USA Inc

Michelle’s career in the healthcare industry began after receiving her BS in Nursing from Belmont University in Nashville TN. Her 20+ year career includes extensive experience in biopharmaceuticals, clinical research, and the medical device industry with several Fortune 500 companies. She is highly skilled in striving within the start-up environment across multitudes of sectors including anesthesiology, cardiology, neurology/multiple sclerosis/intractable seizure disorder, nephrology/liver transplantation, plastic/reconstructive surgery, burn/trauma, radiation/oncology, and gynaecology. Prior to joining CNS she served 12+ years with Biogen; launching their neuroscience product pipeline as well as serving in multiple leadership roles. Michelle represents the US Business Development team for Clinical Network Services (CNS). CNS is an Early Phase CRO, headquartered in Australia with offices in New Zealand, Europe and the USA. With over 20 years of experience on more than 950 projects, CNS is one of the most experienced service providers and a partner of choice for biotech companies


Day 2, April 8 @ 14:40

The advantages of conducting early phase clinical trials in Australia

last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates